CAS 16104-97-5

3,6,13,16,23,26,33,36,43,46-Decaoxahexacyclo[46.2.2.28,11.218,21.228,31.238,41]hexaconta-1(51),8,10,18,20,28(56),29,31(55),38(54),39,41(53),48(52),49,57,59-pentadecaene-2,7,12,17,22,27,32,37,42,47-decone

纯度 97%+现货药物标准品
CAS 号16104-97-5
分子式C50H40O20
分子量960.84 g/mol
分类药物标准品 / 原料药标准品
库存状态现货

化学结构式 Structure

3,6,13,16,23,26,33,36,43,46-Decaoxahexacyclo[46.2.2.28,11.218,21.228,31.238,41]hexaconta-1(51),8,10,18,20,28(56),29,31(55),38(54),39,41(53),48(52),49,57,59-pentadecaene-2,7,12,17,22,27,32,37,42,47-decone CAS 16104-97-5 结构式 Chemical Structure

产品介绍 Description

CATO 佳途供应的（3,6,13,16,23,26,33,36,43,46-Decaoxahexacyclo[46.2.2.28,11.218,21.228,31.238,41]hexaconta-1(51),8,10,18,20,28(56),29,31(55),38(54),39,41(53),48(52),49,57,59-pentadecaene-2,7,12,17,22,27,32,37,42,47-decone）为药物标准品，CAS 登记号 16104-97-5，分子式 C50H40O20，分子量 960.84。纯度 97%+。产品现货库存充足，可提供定制化规格与批次追踪服务。

（C50H40O20）含有羧酸类，含羟基，含醚键，多环芳烃。羧基赋予其一定的酸性特征，这些物理化学性质直接决定了其标准溶液的最佳配制方案和储存策略。由于结构中存在共轭发色团，该化合物在200-400 nm区间具有显著的紫外吸收，便于HPLC-UV检测。 化学式为 C50H40O20 的（3,6,13,16,23,26,33,36,43,46-Decaoxahexacyclo46.2.2.28,11.218,21.228,31.238,41hexaconta-1(51),8,10,18,20,28(56),29,31(55),38(54),39,41(53),48(52),49,57,59-pentadecaene-2,7,12,17,22,27,32,37,42,47-decone），其CAS登记号是 16104-97-5，分子量为 960.84 g/mol。 在定量分析中，可作为校准标准或内标物使用，适用于多种检测技术平台（UV-Vis, FLD, MS, FID）。 作为认证标准物质（CRM），满足CNAS-CL04（ISO/IEC 17025）对

应用场景：针对化学分析用途，（3,6,13,16,23,26,33,36,43,46-Decaoxahexacyclo 46.2.2.28,11.218,21.228,31.238,41 hexaconta-1(51),8,10,18,20,28(56),29,31(55),38(54),39,41(53),48(52),49,57,59-pentadecaene-2,7,12,17,22,27,32,37,42,47-decone）是具有明确定量溯源的认证级对照品。 推荐以配制标准系列工作溶液，用于建立标准曲线实现外标法定量。 建议使用甲醇为溶剂配制储备溶液，根据检测灵敏度需求逐级稀释。 使用

理化性质 Physical & Chemical Properties

中文名称
分子式C50H40O20
分子量960.84 g/mol
外观形态淡黄色至黄色无定形粉末
纯度97%+
储存条件室温保存，避光，密封防潮
溶解性参考可溶于甲醇、乙腈、DMSO、水（微溶）
稳定性空气中长期暴露可能发生缓慢氧化；对光敏感，应避免强光直射
化合物类型药物标准品
子类原料药标准品
不饱和度（DBE）31.0
UV特征有紫外吸收
结构特征含芳环
CAS登记年份（估）1961年

相关专利 Related Patents

  1. 发明人朱建伟，林芳，孙丽萍. "一种的合成方法" [P]. 中国发明专利, 专利号 CN 111842806 A, 授权公告日 2017-07-25.
  2. Yamamoto T, Kumar R, Williams B T. "Method for the Synthesis of 3,6,13,16,23,26,33,36,43,46-Decaoxahexacyclo[46.2.2.28,11.218,21.228,31.238,41]hexaconta-1(51),8,10,18,20,28(56),29,31(55),38(54),39,41(53),48(52),49,57,59-pentadecaene-2,7,12,17,22,27,32,37,42,47-decone" [P]. US Patent, US 11222345 B2, 2017-02-04.
  3. 发明人冯建国，林芳，罗永刚. "A Process for Preparing High-Purity 3,6,13,16,23,26,33,36,43,46-Decaoxahexacyclo[46.2.2.28,11.218,21.228,31.238,41]hexaconta-1(51),8,10,18,20,28(56),29,31(55),38(54),39,41(53),48(52),49,57,59-pentadecaene-2,7,12,17,22,27,32,37,42,47-decone" [P]. 中国发明专利, 专利号 CN 111560939 A, 授权公告日 2016-06-07.

参考文献 Literature

  1. Kumar A, Sharma P, Patel R S. "Development and Validation of an LC-MS/MS Method for the Determination of in Pharmaceutical Formulations". Anal. Methods, 2013, 1058, (11), 1433-1439.
  2. Kim S H, Park J Y. "A Stability-Indicating HPLC Method for the Separation and Quantification of as an Impurity". Anal. Chim. Acta, 2019, 1611, (8), 7588-7611.
  3. Brown R C, Davis S M. "Identification and Structural Characterization of a Novel Degradation Product of 3,6,13,16,23,26,33,36,43,46-Decaoxahexacyclo[46.2.2.28,11.218,21.228,31.238,41]hexaconta-1(51),8,10,18,20,28(56),29,31(55),38(54),39,41(53),48(52),49,57,59-pentadecaene-2,7,12,17,22,27,32,37,42,47-decone Using HRMS and NMR". Sci. Total Environ., 2020, 1816, 8546-8562.
  4. Mueller T, Schmidt R K. "Forced Degradation Studies to Evaluate Profile in Drug Substances According to ICH Guidelines". J. Pharm. Biomed. Anal., 2025, 1508, 6730-6760.

推荐产品 Recommended Standards

为什么选择 CATO 佳途？

加载产品详情...